Immunohistochemical analysis of oxidative stress and DNA repair proteins in normal mammary and breast cancer tissues

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Curtis, Carol D ^a   Thorngren, Daniel L ^a   Nardulli, Ann M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLADENINE DNA GLYCOSYLTRANSFERASE; 3 NITROTYROSINE; 8 HYDROXYGUANINE; COPPER ZINC SUPEROXIDE DISMUTASE; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; DNA GLYCOSYLTRANSFERASE; DNA REPAIR PROTEIN; HISTONE H2AX; NUCLEIC ACID BINDING PROTEIN; PROTEIN DISULFIDE ISOMERASE; REACTIVE OXYGEN METABOLITE; THIOREDOXIN; THIOREDOXIN REDUCTASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST HYPERPLASIA; CANCER INVASION; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DNA DAMAGE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ANIMAL; BIOLOGICAL MODEL; BREAST TUMOR; DISEASE COURSE; DNA REPAIR; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; METABOLISM; METHODOLOGY; PAGET NIPPLE DISEASE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; DISEASE PROGRESSION; DNA DAMAGE; DNA REPAIR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, ANIMAL; MODELS, BIOLOGICAL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 77649106763     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-9     Document Type: Article

References (75)

1. Wiechmann LKH. The molecular journey from ductal carcinoma in situ to invasive breast cancer. Cancer 2008, 112(10):2130-2142. 10.1002/cncr.23430, 18383519.
2. Jacobs TW, Connolly JL, Schnitt SJ. Nonmalignant lesions in breast core needle biopsies: to excise or not to excise?. Am J Surg Pathol 2002, 26(9):1095-1110. 10.1097/00000478-200209000-00001, 12218567.
3. Horak CE, Steeg PS. Metastasis gets site specific. Cancer Cell 2005, 8(2):93-95. 10.1016/j.ccr.2005.07.013, 16098461.
4. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006, 12(8):895-904. 10.1038/nm1469, 16892035.
5. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956, 11(3):298-300.
6. Fridovich I. Fundamental aspects of reactive oxygen species, or what's the matter with oxygen?. Ann N Y Acad Sci 1999, 893:13-18. 10.1111/j.1749-6632.1999.tb07814.x, 10672226.
7. Harman D. Aging: overview. Ann N Y Acad Sci 2001, 928:1-21.
8. Muller FL, Lustgarten MS, Jang Y, Richardson A, Van Remmen H. Trends in oxidative aging theories. Free Radic Biol Med 2007, 43(4):477-503. 10.1016/j.freeradbiomed.2007.03.034, 17640558.
9. Benz CC, Yau C. Ageing, oxidative stress and cancer: paradigms in parallax. Nat Rev Cancer 2008, 8(11):875-879. 10.1038/nrc2522, 2603471, 18948997.
10. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 2002, 33(3):337-349. 10.1016/S0891-5849(02)00905-X, 12126755.
11. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996, 271(5 Pt 1):C1424-1437.
12. Whittal RM, Benz CC, Scott G, Semyonov J, Burlingame AL, Baldwin MA. Preferential oxidation of zinc finger 2 in estrogen receptor DNA-binding domain prevents dimerization and, hence, DNA binding. Biochemistry 2000, 39(29):8406-8417. 10.1021/bi000282f, 10913246.
13. Webster KA, Prentice H, Bishopric NH. Oxidation of zinc finger transcription factors: physiological consequences. Antioxid Redox Signal 2001, 3(4):535-548. 10.1089/15230860152542916, 11554443.
14. Evans AR, Limp-Foster M, Kelley MR. Going APE over ref-1. Mutat Res 2000, 461(2):83-108.
15. Schultz-Norton JR, McDonald WH, Yates JR, Nardulli AM. Protein disulfide isomerase serves as a molecular chaperone to maintain estrogen receptor α structure and function. Mol Endocrinol 2006, 20(9):1982-1995. 10.1210/me.2006-0006, 16690750.
16. Rao AK, Ziegler YS, McLeod IX, Yates JR, Nardulli AM. Effects of Cu/Zn superoxide dismutase on estrogen responsiveness and oxidative stress in human breast cancer cells. Mol Endocrinol 2008, 22(5):1113-1124. 10.1210/me.2007-0381, 2366184, 18258688.
17. Rao AK, Ziegler YS, McLeod IX, Yates JR, Nardulli AM. Thioredoxin and thioredoxin reductase influence estrogen receptor {alpha} mediated gene expression in human breast cancer cells. J Mol Endocrinol 2009, 43(6):251-261. 10.1677/JME-09-0053, 19620238.
18. Curtis CD, Thorngren DL, Ziegler YS, Sarkeshik A, Yates JR, Nardulli AM. Apurinic/apyrimidinic endonuclease 1 alters estrogen receptor activity and estrogen responsive gene expression. Mol Endocrinol 2009, 23(9):1346-1360. 10.1210/me.2009-0093, 19460860.
19. Demple B, Sung JS. Molecular and biological roles of Ape1 protein in mammalian base excision repair. DNA Repair 2005, 4(12):1442-1449. 10.1016/j.dnarep.2005.09.004, 16199212.
20. Sweasy JB, Lang T, DiMaio D. Is base excision repair a tumor suppressor mechanism?. Cell Cycle 2006, 5(3):250-259.
21. Coquerelle T, Dosch J, Kaina B. Overexpression of N-methylpurine-DNA glycosylase in Chinese hamster ovary cells renders them more sensitive to the production of chromosomal aberrations by methylating agents: a case of imbalanced DNA repair. Mutat Res 1995, 336:9-17.
22. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998, 273(10):5858-5868. 10.1074/jbc.273.10.5858, 9488723.
23. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 2000, 10(15):886-895. 10.1016/S0960-9822(00)00610-2, 10959836.
24. Bertram JS. The molecular biology of cancer. Mol Aspects Med 2000, 21(6):167-223. 10.1016/S0098-2997(00)00007-8, 11173079.
25. Likhite VS, Cass EI, Anderson SD, Yates JR, Nardulli AM. Interaction of estrogen receptor alpha with 3-methyladenine DNA glycosylase modulates transcription and DNA repair. J Biol Chem 2004, 279(16):16875-16882. 10.1074/jbc.M313155200, 14761960.
26. Curtis CD, Likhite VS, McLeod IX, Yates JR, Nardulli AM. Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor alpha alters estrogen-responsive gene expression. Cancer Res 2007, 67(21):10600-10607. 10.1158/0008-5472.CAN-07-0055, 17975005.
27. Hartsough MT, Steeg PS. Nm23/nucleoside diphosphate kinase in human cancers. J Bioenerg Biomembr 2000, 32(3):301-308. 10.1023/A:1005597231776, 11768314.
28. Bertheau P, Steinberg SM, Merino MJ. C-erbB-2, p53, and nm23 gene product expression in breast cancer in young women: immunohistochemical analysis and clinicopathologic correlation. Hum Pathol 1998, 29(4):323-329. 10.1016/S0046-8177(98)90111-3, 9563780.
29. Duenas-Gonzalez A, Abad-Hernandez MM, Garcia-Mata J, Paz-Bouza JI, Cruz-Hernandez JJ, Gonzalez-Sarmiento R. Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings. Cancer Lett 1996, 101(2):137-142. 10.1016/0304-3835(96)04131-6, 8620461.
30. Yoshida H, Kijima H, Terasaki Y, Suto A, Takeshita T, Omiya H, Shimojima K, Shimbori M, Sato T, Sato S, et al. Heterogeneous expression of nm23 gene product as a predictor of lymph nodal status in human breast cancer. Int J Oncol 1998, 13(6):1141-1146.
31. Schultz-Norton JR, Ziegler YS, Likhite VS, Nardulli AM. Isolation of proteins associated with the DNA-bound estrogen receptor α. Molecular Endocrinology: A Comprehensive Guide to Current Methodologies 2009, 590:209-221. Totowa, NJ: Humana Press, USA, Park Sarge O-K, Curry T.
32. Schultz-Norton JR, Ziegler YS, Likhite VS, Yates JR, Nardulli AM. Isolation of novel coregulatory protein networks associated with DNA-bound estrogen receptor alpha. BMC Mol Biol 2008, 9:97. 10.1186/1471-2199-9-97, 2585101, 18973695.
33. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci USA 1997, 94(8):3633-3638. 10.1073/pnas.94.8.3633, 20492, 9108029.
34. Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S, Prives C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev 1997, 11(5):558-570. 10.1101/gad.11.5.558, 9119221.
35. Grzenkowicz-Wydra J, Cisowski J, Nakonieczna J, Zarebski A, Udilova N, Nohl H, Jozkowicz A, Podhajska A, Dulak J. Gene transfer of CuZn superoxide dismutase enhances the synthesis of vascular endothelial growth factor. Mol Cell Biochem 2004, 264(1-2):169-181. 10.1023/B:MCBI.0000044386.45054.70, 15544046.
36. Juarez JC, Betancourt O, Pirie-Shepherd SR, Guan X, Price ML, Shaw DE, Mazar AP, Donate F. Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1. Clin Cancer Res 2006, 12(16):4974-4982. 10.1158/1078-0432.CCR-06-0171, 16914587.
37. Mustacich D, Powis G. Thioredoxin reductase. Biochem J 2000, 346(Pt 1):1-8. 10.1042/0264-6021:3460001, 1220815, 10657232.
38. Bobola MS, Blank A, Berger MS, Stevens BA, Silber JR. Apurinic/apyrimidinic endonuclease activity is elevated in human adult gliomas. Clin Cancer Res 2001, 7(11):3510-3518.
39. Kelley MR, Cheng L, Foster R, Tritt R, Jiang J, Broshears J, Koch M. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin Cancer Res 2001, 7(4):824-830.
40. Robertson KA, Bullock HA, Xu Y, Tritt R, Zimmerman E, Ulbright TM, Foster RS, Einhorn LH, Kelley MR. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res 2001, 61(5):2220-2225.
41. Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB, Von Hoff DD. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 2002, 62(10):2890-2896.
42. Lincoln DT, Ali Emadi EM, Tonissen KF, Clarke FM. The thioredoxin-thioredoxin reductase system: over-expression in human cancer. Anticancer Res 2003, 23(3B):2425-2433.
43. Turunen N, Karihtala P, Mantyniemi A, Sormunen R, Holmgren A, Kinnula VL, Soini Y. Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma. Apmis 2004, 112(2):123-132. 10.1111/j.1600-0463.2004.apm1120207.x, 15056229.
44. Powis G, Mustacich D, Coon A. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic Biol Med 2000, 29(3-4):312-322. 10.1016/S0891-5849(00)00313-0, 11035260.
45. Welsh SJ, Bellamy WT, Briehl MM, Powis G. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1α protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res 2002, 62(17):5089-5095.
46. Smart DK, Ortiz KL, Mattson D, Bradbury CM, Bisht KS, Sieck LK, Brechbiel MW, Gius D. Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress. Cancer Res 2004, 64(18):6716-6724. 10.1158/0008-5472.CAN-03-3990, 15374989.
47. Burke-Gaffney A, Callister ME, Nakamura H. Thioredoxin: friend or foe in human disease?. Trends Pharmacol Sci 2005, 26(8):398-404. 10.1016/j.tips.2005.06.005, 15990177.
48. Zou GM, Luo MH, Reed A, Kelley MR, Yoder MC. Ape1 regulates hematopoietic differentiation of embryonic stem cells through its redox functional domain. Blood 2007, 109(5):1917-1922. 10.1182/blood-2006-08-044172, 17053053.
49. Fishel ML, Kelley MR. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. Mol Aspects Med 2007, 28(3-4):375-395. 10.1016/j.mam.2007.04.005, 17560642.
50. Mukherjee A, Martin SG. The thioredoxin system: a key target in tumour and endothelial cells. Br J Radiol 2008, 81(Spec No 1):S57-68. 10.1259/bjr/34180435, 18819999.
51. Goplen D, Wang J, Enger PO, Tysnes BB, Terzis AJ, Laerum OD, Bjerkvig R. Protein disulfide isomerase expression is related to the invasive properties of malignant glioma. Cancer Res 2006, 66(20):9895-9902. 10.1158/0008-5472.CAN-05-4589, 17047051.
52. Hansen WK, Kelley MR. Review of mammalian DNA repair and translational implications. J Pharmacol Exp Ther 2000, 295(1):1-9.
53. Scharer OD, Jiricny J. Recent progress in the biology, chemistry and structural biology of DNA glycosylases. Bioessays 2001, 23:270-281. 10.1002/1521-1878(200103)23:3<270::AID-BIES1037>3.0.CO;2-J, 11223884.
54. Fishel ML, Seo YR, Smith ML, Kelley MR. Imbalancing the DNA base excision repair pathway in the mitochondria; targeting and overexpressing N-methylpurine DNA glycosylase in mitochondria leads to enhanced cell killing. Cancer Res 2003, 63(3):608-615.
55. Rinne M, Caldwell D, Kelley MR. Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells. Mol Cancer Ther 2004, 3(8):955-967.
56. Engelward BP, Allan JM, Dreslin AJ, Kelly JD, Wu MM, Gold B, Samson LD. A chemical and genetic approach together define the biological consequences of 3-methyladenine lesions in the mammalian genome. J Biol Chem 1998, 273:5412-5418. 10.1074/jbc.273.9.5412, 9479003.
57. Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 2003, 112(5):659-672. 10.1016/S0092-8674(03)00150-8, 12628186.
58. Chowdhury D, Beresford PJ, Zhu P, Zhang D, Sung JS, Demple B, Perrino FW, Lieberman J. The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death. Mol Cell 2006, 23(1):133-142. 10.1016/j.molcel.2006.06.005, 16818237.
59. Steeg PS. Search for metastasis suppressor genes. Invasion Metastasis 1989, 9(6):351-359.
60. Steeg PS, Palmieri D, Ouatas T, Salerno M. Histidine kinases and histidine phosphorylated proteins in mammalian cell biology, signal transduction and cancer. Cancer Lett 2003, 190(1):1-12. 10.1016/S0304-3835(02)00499-8, 12536071.
61. Steeg PS, Ouatas T, Halverson D, Palmieri D, Salerno M. Metastasis suppressor genes: basic biology and potential clinical use. Clin Breast Cancer 2003, 4(1):51-62. 10.3816/CBC.2003.n.012, 12744759.
62. Heimann R, Ferguson DJ, Hellman S. The relationship between nm23, angiogenesis, and the metastatic proclivity of node-negative breast cancer. Cancer Res 1998, 58(13):2766-2771.
63. Leone A, Flatow U, VanHoutte K, Steeg PS. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 1993, 8(9):2325-2333.
64. Russell RL, Pedersen AN, Kantor J, Geisinger K, Long R, Zbieranski N, Townsend A, Shelton B, Brunner N, Kute TE. Relationship of nm23 to proteolytic factors, proliferation and motility in breast cancer tissues and cell lines. Br J Cancer 1998, 78(6):710-717. 2062960, 9743288.
65. Li Z, Xiang J, Zhang W, Fan S, Wu M, Li X, Li G. Nanoparticle delivery of anti-metastatic NM23-H1 gene improves chemotherapy in a mouse tumor model. Cancer Gene Ther 2009, 16(5):423-429. 10.1038/cgt.2008.97, 19096443.
66. Malins DC, Haimanot R. Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res 1991, 51(19):5430-5432.
67. Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett 1995, 358(1):1-3. 10.1016/0014-5793(94)01368-B, 7821417.
68. Malins DC, Anderson KM, Jaruga P, Ramsey CR, Gilman NK, Green VM, Rostad SW, Emerman JT, Dizdaroglu M. Oxidative changes in the DNA of stroma and epithelium from the female breast: potential implications for breast cancer. Cell Cycle 2006, 5(15):1629-1632.
69. Beckman JS, Carson M, Smith CD, Koppenol WH. ALS, SOD and peroxynitrite. Nature 1993, 364(6438):584. 10.1038/364584a0, 8350919.
70. Squadrito GL, Pryor WA. Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic Biol Med 1998, 25(4-5):392-403. 10.1016/S0891-5849(98)00095-1, 9741578.
71. Bianchi MS, Bianchi NO, Bolzan AD. Superoxide dismutase activity and superoxide dismutase-1 gene methylation in normal and tumoral human breast tissues. Cancer Genet Cytogenet 1992, 59(1):26-29. 10.1016/0165-4608(92)90152-X, 1555188.
72. Starcevic SL, Diotte NM, Zukowski KL, Cameron MJ, Novak RF. Oxidative DNA damage and repair in a cell lineage model of human proliferative breast disease (PBD). Toxicol Sci 2003, 75(1):74-81. 10.1093/toxsci/kfg154, 12805649.
73. Wang D, Luo M, Kelley MR. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Mol Cancer Ther 2004, 3(6):679-686.
74. McNeill DR, Wilson DM. A dominant-negative form of the major human abasic endonuclease enhances cellular sensitivity to laboratory and clinical DNA-damaging agents. Mol Cancer Res 2007, 5(1):61-70. 10.1158/1541-7786.MCR-06-0329, 17259346.
75. Brown DP, Chin-Sinex H, Nie B, Mendonca MS, Wang M. Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer. Cancer Chemother Pharmacol 2009, 63(4):723-730. 10.1007/s00280-008-0791-x, 18622615.